Posted February 08, 2018 02:16:24 The Sacred Heart Hospital in Arkadelphia, Arkansas, is proud to announce that they are the first hospital in the state to be awarded the Children’s Cancer Research & Treatment Award.
In 2015, the Sacred Hearts was recognized by the National Institute of Allergy and Infectious Diseases (NIAID) for its dedication to the prevention and treatment of pediatric cancers.
The hospital received its first National Breast Cancer Screening Program grant in 2017, which included funding for a new biorepository, a new pediatric imaging system, and the development of a pediatric immunotherapy and immunosuppressant for children with breast cancer.
The new biostatistics system is being developed for the pediatric immunosound project, which is currently underway at the Sacremento Health Science Center in New Mexico.
The biostats will be used to test for the antibodies to the breast cancer virus and its variants.
The immunosurveys are expected to be completed by the end of 2019.
The Sacrements’ research will continue to improve the quality of life for pediatric patients with cancer.
In 2016, the hospital received $7 million in funding to expand the biostatic system.
The Biostatistic System is a portable, wearable device designed to test and measure antibodies to breast cancer viruses, the BCRVs, in the bloodstream.
The system will help researchers develop better vaccines for children who have breast cancer, which will help save the lives of children who may be suffering from breast cancer as a result of other diseases.
The research has been supported by the Robert Wood Johnson Foundation, the National Institutes of Health, and private donations.
The National Breast Cancers Screening and Research Program is a federal program that helps fund clinical research to detect and cure breast cancer and cancer-related complications.
For more information about the Sacres, visit the Sacrificial Heart.
Read more articles from Arkansas Today